BILLERICA, Mass.--(BUSINESS WIRE)--Jun. 15, 2009-- Bruker Corporation (NASDAQ: BRKR) announced today that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) relating to the registration of seventy million (70,000,000) shares of its common stock, consisting of both primary and secondary shares.
Under the shelf registration, if and when declared effective by the SEC, three of the Company’s major Laukien shareholders may, from time to time, in one or more offerings offer for resale up to thirty five million (35,000,000) secondary shares in the aggregate, at prices and on terms to be determined at the time of any such offering. Frank Laukien, the Company’s President and CEO, and two other Laukien shareholders are not registering for resale in this filing any shares of Company common stock owned by them.
In addition, if and when the SEC declares this shelf registration effective, the Company may, from time to time, in one or more offerings and at prices and on terms to be determined at the time of an offering, if any, offer for sale up to thirty five million (35,000,000) primary shares of common stock. The Company presently has no intentions to offer any such primary shares.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.
ABOUT BRUKER CORPORATION
Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. For more information about Bruker Corporation, please visitwww.energie2point0.com.
CAUTIONARY STATEMENT
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to adverse changes in conditions in the global economy and volatility in the capital markets, the integration of businesses we have acquired or may acquire in the future, changing technologies, product development and market acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, intellectual property rights, litigation, and exposure to foreign currency fluctuations. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2008, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements other than as required by law.
Source: Bruker Corporation
Bruker Corporation
Stacey Desrochers, +1-978-663-3660, ext. 1115
Director of Investor Relations
stacey.desrochers@bruker.com